Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors (Q37691597)
Jump to navigation
Jump to search
scientific article published on 19 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors |
scientific article published on 19 February 2014 |
Statements
1 reference
Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors (English)
1 reference
Shari L Sutor
Catherine J Huntoon
1 reference